Baseline levels determine magnitude of increment in 25 hydroxy vitamin D following vitamin D3 prescription in healthy subjects
- 23 Downloads
Vitamin D deficiency is a major health problem which affects about one billion people in the world. Although, vitamin D supplementation is recommended as standard treatment of vitamin D deficiency, there are controversies on dose response relationship. In this regard, the present study aimed to determine the impact of vitamin D3 supplement on raising of serum 25 hydroxyvitamin D[25(OH)D] in healthy subjects with varying degrees of vitamin D deficiency.
Materials and methods
In this clinical trial 114 subjects with varying degrees of vitamin D deficiency were entered and divided into three groups: serum levels of 25(OH) D less than 10 ng/ml, 10–20 ng/ml, and 20–30 ng/ml. All of the participants were given 50,000 units vitamin D3 per week for 8 weeks, thereafter, changes in serum levels of vitamin D and PTH were evaluated at week twelve. The results were analyzed using SPSS version 16 and P < 0.05 was considered to be significant.
Of the 114 vitamin D deficient subjects, serum level of vitamin D was below 10 ng/ml in 22 persons (19.3%), 10–20 ng/ml in 52 persons (45.6%) and 20–30 ng/ml in 40 persons (35.1%). Following vitamin D prescription all people with varying degrees of vitamin D deficiency obtained a favorable serum level. The increase in vitamin D levels were 26.4, 18.5, and 8.3 ng/ml, in individuals with baseline vitamin D levels below 10 ng/ml, 10–20 ng/ml and 20–30 ng/ml, respectively. The changes in 25(OH) vitamin D in all three groups were significant (P < 0.05), nonetheless no significant alterations in serum levels of PTH were observed (P > 0.05).
Our results indicated an inverse relationship between baseline serum levels of 25(OH) D and its increment following treatment with vitamin D3. Therefore, the magnitude of increments in serum 25(OH) D is greater in subjects with lower baseline levels of 25(OH) D.
KeywordsVitamin D deficiency Dose response relationship Treatment
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.S.H. Masood, M.P. Iqbal, Prevalence of vitamin D deficiency in South Asia. Angiogenesis 1, 12 (2008)Google Scholar
- 5.M.F. Holick, in Evolution and Function of Vitamin D. In: Reichrath J., Tilgen W., Friedrich M. (eds). Vitamin D Analogs in Cancer Prevention and Therapy. Recent Results in Cancer Research, vol 164. (Springer, Berlin, Heidelberg, 2003) pp. 3–28Google Scholar
- 7.H.A.P. Harant, G.S. Reddy, E. Foglar, I.J.D. Lindley, 1 alpha,25-dihydroxyvitamin D-3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappa B-mediated interleukin-8 gene expression. Eur. J. Biochem. 250, 63–71 (1997)Google Scholar
- 9.M. Juonala, A. Voipio, K. Pahkala, J.S. Viikari, V. Mikkilä, M. Kähönen, N. Hutri-Kähönen, A. Jula, D. Burgner, M.A. Sabin, Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study. The. J. Clin. Endocrinol. Metab. 100, 1469–1476 (2015)CrossRefGoogle Scholar
- 12.R. Chowdhury, S. Kunutsor, A. Vitezova, C. Oliver-Williams, S. Chowdhury, J.C. Kiefte-de-Jong, H. Khan, C.P. Baena, D. Prabhakaran, M.B. Hoshen, Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903 (2014)CrossRefGoogle Scholar
- 13.P. Bergman, A.-C. Norlin, S. Hansen, R.S. Rekha, B. Agerberth, L. Björkhem-Bergman, L. Ekström, J.D. Lindh, J. Andersson, Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open 2, e001663 (2012)CrossRefGoogle Scholar
- 15.P. Pludowski, M.F. Holick, S. Pilz, C.L. Wagner, B.W. Hollis, W.B. Grant, Y. Shoenfeld, E. Lerchbaum, D.J. Llewellyn, K. Kienreich, Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—a review of recent evidence. Autoimmun. Rev. 12, 976–989 (2013)CrossRefGoogle Scholar
- 16.J.-C. Souberbielle, J.-J. Body, J.M. Lappe, M. Plebani, Y. Shoenfeld, T.J. Wang, H.A. Bischoff-Ferrari, E. Cavalier, P.R. Ebeling, P. Fardellone, Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun. Rev. 9, 709–715 (2010)CrossRefGoogle Scholar
- 23.L.B.F. Cianferotti, H.A. Bischoff-Ferrari, O. Bruyere, C. Cooper, M. Cutolo, J.A. Kanis, J.M. Kaufman, J.Y. Reginster, R. Rizzoli, M.L. Brandi, Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Endocrine 56, 245–261 (2017)CrossRefGoogle Scholar
- 24.P. Płudowski, E. Karczmarewicz, M. Bayer, G. Carter, D. Chlebna-Sokół, J. Czech-Kowalska, R. Dębski, T. Decsi, A. Dobrzańska, E. Franek, Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe—recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol. Pol. 64, 319–327 (2013)CrossRefGoogle Scholar
- 25.M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011)CrossRefGoogle Scholar
- 26.A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96, 53–58 (2011)CrossRefGoogle Scholar
- 37.A. Shieh, C. Ma, R.F. Chun, J. Wittwer-Schegg, L. Swinkels, T. Huijs, J. Wang, I. Donangelo, M. Hewison, J.S. Adams, Associations between change in total and free 25-hydroxyvitamin D with 24, 25-dihydroxyvitamin D and parathyroid hormone. J. Clin. Endocrinol. Metab. 8, e1187349 (2018)Google Scholar
- 44.R.A. Durazo-Arvizu, B. Dawson-Hughes, H. Kramer, G. Cao, J. Merkel, P.M. Coates, C.T. Sempos, The reverse J-shaped association between serum total 25-hydroxyvitamin D concentration and all-cause mortality: the impact of assay standardization. Am. J. Epidemiol. 185, 720–726 (2017)CrossRefGoogle Scholar